Funding for interdisciplinary MSCA doctoral training network about targeting RNA with small molecules
TargetRNA is an EU Horizon funded Marie Skłodowska-Curie Action (MSCA) doctoral training network. In this network, 16 PhD students will be trained in RNA-ligand design in the context of antimicrobial drug discovery.
Main content
I am thrilled to announce that the EU commission has funded our application for an MSCA doctoral training network about targeting RNA with small molecules (TargetRNA).
The TargetRNA network aims to educate and nurture the next generation of scientists with cutting-edge interdisciplinary skills in the discovery and biological characterization of RNA modulators and thus generate fundamental knowledge on what drives affinity and specificity of small molecules binding to RNA. We will focus on developing antimicrobial tool compounds to selectively reshape the human gut microbiome by targeting RNA, an area with vast implications for medicine. Training through research activities, spanning from computational and medicinal chemistry over structural and molecular biology to microbiology and in vivo models, will be supplemented by an innovative training program in specific and transferable skills for interdisciplinary drug discovery strategies to target RNA, including FAIR data principles, open science practices as well as responsible development and sustainable implementation of new innovations. To achieve the ambitious research and training goals, the TargetRNA network unites leading scientists from 13 academic partners (8 beneficiaries, 5 associated) and 4 industry partners (1 beneficiaries, 3 associated) based in 9 countries.
More informations about the network can be found here.
There are 16 Phd postionsin the network and information on how to apply can be found here.